Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA-Reference-Cited by-同舟云学术

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA

Published:2022-10-18 Issue:20 Volume:11 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Ranasinghe Priyanga¹²^ORCID,Addison Melisande L.²^ORCID,Webb David J.²^ORCID

Affiliation:

1. Faculty of Medicine, Department of Pharmacology University of Colombo Colombo Sri Lanka

2. University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh Edinburgh United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

2. Conducting Research on the Economics of Hypertension to Improve Cardiovascular Health

3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

4. Aliskiren, an Orally Effective Renin Inhibitor, Provides Antihypertensive Efficacy Alone and in Combination With Valsartan

5. Abstract 14387: Dose‐related reductions in blood pressure with a rna interference (rnai) therapeutic targeting angiotensinogen in hypertensive patients: Interim results from a first‐in‐human phase 1 study of aln‐agt01;Huang S;Circulation,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The art of healing hearts: Mastering advanced RNA therapeutic techniques to shape the evolution of cardiovascular medicine in biomedical science;Current Problems in Cardiology;2024-08

2. Zilebesiran: The First siRNA Drug Therapy for Hypertension;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-11

3. RNA in cardiovascular disease: A new frontier of personalized medicine;Progress in Cardiovascular Diseases;2024-07

4. Hypertension and Heart Failure: From Pathophysiology to Treatment;International Journal of Molecular Sciences;2024-06-17

5. Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-04